Back to Journals » Neuropsychiatric Disease and Treatment » Volume 17

Neuropsychiatric Disease and Treatment


Archive: Volume 17, 2021

Adverse Drug Reaction and Its Predictors Among Psychiatric Patients Taking Psychotropic Medications at the Mizan-Tepi University Teaching Hospital

Ejeta F, Aferu T, Feyisa D, Kebede O, Siraj J, Hammeso WW, Tadesse E, Tinishku A

Neuropsychiatric Disease and Treatment 2021, 17:3827-3835

Published Date: 29 December 2021

QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review

Torres-Yaghi Y, Carwin A, Carolan J, Nakano S, Amjad F, Pagan F

Neuropsychiatric Disease and Treatment 2021, 17:3791-3818

Published Date: 24 December 2021

Therapeutic Potential of Vortioxetine for Anxious Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan

Inoue T, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Watanabe K

Neuropsychiatric Disease and Treatment 2021, 17:3781-3790

Published Date: 21 December 2021

EMT-Related Markers in Serum Exosomes are Potential Diagnostic Biomarkers for Invasive Pituitary Adenomas

Chen K, Li G, Kang X, Liu P, Qian L, Shi Y, Osman RA, Yang Z, Zhang G

Neuropsychiatric Disease and Treatment 2021, 17:3769-3780

Published Date: 21 December 2021

Resting-State Functional Magnetic Resonance Imaging Reveals Overactivation of the Habitual Control Brain System in Tobacco Dependence

Tan Q, Li S, Niu J, Liu S, Li Y, Lu Y, Wang Z, Xu W, Wei Y, Guo Z

Neuropsychiatric Disease and Treatment 2021, 17:3753-3768

Published Date: 19 December 2021

Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan

Inoue T, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Watanabe K

Neuropsychiatric Disease and Treatment 2021, 17:3735-3741

Published Date: 18 December 2021

Effect of Deep Brain Stimulation on Female Parkinsonian Patients with Lower Urinary Tract Symptoms

Liang F, Tang Y, Bi K, Liu X, Li C, Chen S, Zhang C, Yan L, Xu Z, Yang N

Neuropsychiatric Disease and Treatment 2021, 17:3727-3733

Published Date: 18 December 2021

Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms

Ruetsch C, Davis T, Liberman JN, Velligan DI, Robinson D, Jaeger C, Carpenter W, Forma F

Neuropsychiatric Disease and Treatment 2021, 17:3715-3726

Published Date: 16 December 2021

Selective Impairment of Processing Task-Irrelevant Emotional Faces in Cerebral Small Vessel Disease Patients

Fan Z, Guo Y, Hou X, Lv R, Nie S, Xu S, Chen J, Hong Y, Zhao S, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:3693-3703

Published Date: 16 December 2021

Paliperidone Compared with Haloperidol on the Theory of Mind Tasks in Schizophrenia: A Pilot Trial

Zhong J, Zhu H, Yin D, Ning Y, Zheng S, Zhang Y, Jia H

Neuropsychiatric Disease and Treatment 2021, 17:3683-3691

Published Date: 14 December 2021

From Personalized Medicine to Precision Psychiatry?

Češková E, Šilhán P

Neuropsychiatric Disease and Treatment 2021, 17:3663-3668

Published Date: 14 December 2021

Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study

Matsuzaki H, Hatano M, Iwata M, Yamada S

Neuropsychiatric Disease and Treatment 2021, 17:3655-3661

Published Date: 14 December 2021

LncRNA FTX Regulates Angiogenesis Through miR-342-3p/SPI1 Axis in Stroke

Gao Q, Wang Y

Neuropsychiatric Disease and Treatment 2021, 17:3617-3625

Published Date: 11 December 2021

Relationship Among Homocysteine, Inflammation and Cognitive Impairment in Patients with Acute Ischemic Stroke and Transient Ischemic Attack

Cui L, Lu P, Li S, Pan Y, Wang M, Li Z, Liao X, Wang Y

Neuropsychiatric Disease and Treatment 2021, 17:3607-3616

Published Date: 11 December 2021

Cariprazine in Three Special Different Areas: A Real-World Experience

Gesi C, Paletta S, Palazzo M C, Dell'Osso B, Mencacci C, Cerveri G

Neuropsychiatric Disease and Treatment 2021, 17:3581-3588

Published Date: 7 December 2021

MRI Evaluation of the Relationship Between Abnormalities in Vision-Related Brain Networks and Quality of Life in Patients with Migraine without Aura

Cui W, Zhang J, Xu F, Zhi H, Li H, Li B, Zhang S, Peng W, Wu H

Neuropsychiatric Disease and Treatment 2021, 17:3569-3579

Published Date: 8 December 2021

The Role of PAX2 in Neurodevelopment and Disease

Lv N, Wang Y, Zhao M, Dong L, Wei H

Neuropsychiatric Disease and Treatment 2021, 17:3559-3567

Published Date: 7 December 2021

Association of Versican Gene Polymorphisms with Intracranial Aneurysm Susceptibility in the Eastern Chinese Population

Zhu L, Yu C, Zhou S, Xue M, Chen J, Wu M, Dong S, Huang G, Chang Y, Zhang M

Neuropsychiatric Disease and Treatment 2021, 17:3531-3537

Published Date: 7 December 2021

Challenges Surrounding the Diagnosis of Autism in Children

Hus Y, Segal O

Neuropsychiatric Disease and Treatment 2021, 17:3509-3529

Published Date: 3 December 2021

Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson’s Disease

Zhong M, Jiang X, Zhu S, Gu R, Bai Y, He H, Pan Y, Xu P, Yan J, Zhang L

Neuropsychiatric Disease and Treatment 2021, 17:3499-3508

Published Date: 3 December 2021

The Relationship Between Antipsychotic-Induced Akathisia and Suicidal Behaviour: A Systematic Review

Kalniunas A, Chakrabarti I, Mandalia R, Munjiza J, Pappa S

Neuropsychiatric Disease and Treatment 2021, 17:3489-3497

Published Date: 3 December 2021

Reduced Plasma Estradiol Levels are Associated with Sleep Apnea in Depressed Peri- and Post-Menopausal Women

Cai L, Huang L, Wei L, Yao J, Xu L, Chen W

Neuropsychiatric Disease and Treatment 2021, 17:3483-3488

Published Date: 2 December 2021

Predictors of Neurological Presentations of COVID-19 Infected Patients in South Egypt, Aswan Governorate: A Single Center Study

Tony AA, Ahmed SBA, Tony EAE, Maklad S, Elnakeeb I, Amin MM

Neuropsychiatric Disease and Treatment 2021, 17:3471-3482

Published Date: 1 December 2021

Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials

Borentain S, Williamson D, Turkoz I, Popova V, McCall WV, Mathews M, Wiegand F

Neuropsychiatric Disease and Treatment 2021, 17:3459-3470

Published Date: 30 November 2021

Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults

Zaccara G, Lattanzi S, Leo A, Russo E

Neuropsychiatric Disease and Treatment 2021, 17:3447-3457

Published Date: 30 November 2021

Rumination Mediates the Effects of Childhood Maltreatment and Trait Anxiety on Depression in Non-Clinical Adult Volunteers

Deguchi A, Masuya J, Naruse M, Morishita C, Higashiyama M, Tanabe H, Inoue T, Ichiki M

Neuropsychiatric Disease and Treatment 2021, 17:3439-3445

Published Date: 23 November 2021

Analysis of Risk Factors for Poor Short-Term Outcomes in Acute Cardioembolic Stroke Patients without Reperfusion Therapy

Guo Y, Zhang M, Su Y, Liu J, Fu H, Wang Q, Chen Y

Neuropsychiatric Disease and Treatment 2021, 17:3431-3437

Published Date: 23 November 2021

Identification of Bonding Difficulties in the Peripartum Period Using the Mother-to-Infant Bonding Scale-Japanese Version and Its Tentative Cutoff Points

Hashijiri K, Watanabe Y, Fukui N, Motegi T, Ogawa M, Egawa J, Enomoto T, Someya T

Neuropsychiatric Disease and Treatment 2021, 17:3407-3413

Published Date: 20 November 2021

Content Validation of an Algorithm for the Assessment, Management and Monitoring of Drug-Induced QTc Prolongation in the Psychiatric Population

Zolezzi M, Elhakim A, Elamin WM, Homs S, Mahmoud DE, Qubaiah IA

Neuropsychiatric Disease and Treatment 2021, 17:3395-3405

Published Date: 19 November 2021

Preliminary Findings on Visual Event-Related Potential P3 in Asymptomatic Patients with Cerebral Small Vessel Disease

Nie S, Shen C, Guo Y, Hou X, Hong Y, Xu S, Lv R, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:3379-3394

Published Date: 18 November 2021

Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review

Woranush W, Moskopp ML, Sedghi A, Stuckart I, Noll T, Barlinn K, Siepmann T

Neuropsychiatric Disease and Treatment 2021, 17:3359-3377

Published Date: 19 November 2021

Dopamine and Neuroinflammation in Schizophrenia – Interpreting the Findings from Translocator Protein (18kDa) PET Imaging

Iliopoulou SM, Tsartsalis S, Kaiser S, Millet P, Tournier BB

Neuropsychiatric Disease and Treatment 2021, 17:3345-3357

Published Date: 18 November 2021

Association of Two Variable Number of Tandem Repeats in the Monoamine Oxidase A Gene Promoter with Schizophrenia

Tanifuji T, Okazaki S, Otsuka I, Horai T, Shinko Y, Kim S, Sora I, Hishimoto A

Neuropsychiatric Disease and Treatment 2021, 17:3315-3323

Published Date: 11 November 2021

Not All Cases of Visual Snows are Benign: Mimics of Visual Snow Syndrome

Hang C, Leishangthem L, Yan Y

Neuropsychiatric Disease and Treatment 2021, 17:3293-3300

Published Date: 10 November 2021

Retinal Imaging Techniques Based on Machine Learning Models in Recognition and Prediction of Mild Cognitive Impairment

Zhang Q, Li J, Bian M, He Q, Shen Y, Lan Y, Huang D

Neuropsychiatric Disease and Treatment 2021, 17:3267-3281

Published Date: 6 November 2021

High Serum S100A12 Levels Predict Poor Outcome After Acute Primary Intracerebral Hemorrhage

Qiu SZ, Zheng GR, Ma CY, Chen B, Huang JJ, Huang G, Hua H

Neuropsychiatric Disease and Treatment 2021, 17:3245-3253

Published Date: 2 November 2021

Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records

Ker S, Hsu J, Balani A, Mukherjee SS, Rush AJ, Khan M, Elchehabi S, Huffhines S, DeMoss D, Rentería ME, Sarkar J

Neuropsychiatric Disease and Treatment 2021, 17:3229-3244

Published Date: 28 October 2021

Treatment Strategies for Cryptogenic Stroke Patients with Patent Foramen Ovale: What Do We Choose?

Shen Y, Nie Q, Zhang Y, Cao Q, Hou Z, Xu L

Neuropsychiatric Disease and Treatment 2021, 17:3205-3214

Published Date: 22 October 2021

Herbal Medicine for Patients with Cognitive Impairment: An Observational Study

Choi Y, Kim AR, Lee JY, Kim HS, Yang C, Kim JK, Go Y, Jung IC

Neuropsychiatric Disease and Treatment 2021, 17:3183-3194

Published Date: 21 October 2021

Victimization in Childhood Mediates the Association Between Parenting Quality, Stressful Life Events, and Depression in Adulthood

Ishii Y, Masuya J, Morishita C, Higashiyama M, Inoue T, Ichiki M

Neuropsychiatric Disease and Treatment 2021, 17:3171-3182

Published Date: 19 October 2021

Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate Among Veterans with Schizophrenia

El Khoury AC, Patel C, Mavros P, Huang A, Wang L, Bashyal R

Neuropsychiatric Disease and Treatment 2021, 17:3159-3170

Published Date: 19 October 2021

Inhibition of miR-448-3p Attenuates Cerebral Ischemic Injury by Upregulating Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)

Xu M, Xiang D, Wang W, Chen L, Lu W, Cheng F

Neuropsychiatric Disease and Treatment 2021, 17:3147-3158

Published Date: 19 October 2021

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]

Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D

Neuropsychiatric Disease and Treatment 2021, 17:3135-3136

Published Date: 15 October 2021

Tardive Dyskinesia in Older Persons Taking Antipsychotics

Citrome L, Isaacson SH, Larson D, Kremens D

Neuropsychiatric Disease and Treatment 2021, 17:3127-3134

Published Date: 14 October 2021

Effectiveness and Safety of Pressure Dressings on Reducing Subdural Effusion After Decompressive Craniectomy

Huang W, Zhou B, Li Y, Shao Y, Peng B, Jiang X, Xiang T

Neuropsychiatric Disease and Treatment 2021, 17:3119-3125

Published Date: 14 October 2021

Association Between the A118G Polymorphism of the OPRM1 Gene and Suicidal Depression in a Large Cohort of Outpatients with Depression

Nobile B, Olie E, Ramoz N, Dubois J, Guillaume S, Gorwood P, Courtet P

Neuropsychiatric Disease and Treatment 2021, 17:3109-3118

Published Date: 14 October 2021

Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis

Sakai C, Tsuji T, Nakai T, Namba Y, Mishima H, Fujiwara M, Matsunaga H

Neuropsychiatric Disease and Treatment 2021, 17:3097-3108

Published Date: 11 October 2021

Can Goal-Based Health Management Improve the Health Knowledge, Health Belief and Health Behavior in People at High Risk of Stroke? A Non-Randomized Controlled Trial

He Y, Guo L, Liu Y, Wei M, Guo Y, Dong X, Yang C, Zhou Q, Lei X, Zhang G, Zhang M

Neuropsychiatric Disease and Treatment 2021, 17:3085-3095

Published Date: 8 October 2021

Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment

Moga S, Teodorescu A, Ifteni P, Gavris C, Petric PS

Neuropsychiatric Disease and Treatment 2021, 17:3053-3060

Published Date: 2 October 2021

Parents of Children Diagnosed with Autism Spectrum Disorder: What Do They Expect and Experience from Preschools?

Westman Andersson G, Gillberg N, Miniscalco C

Neuropsychiatric Disease and Treatment 2021, 17:3025-3037

Published Date: 28 September 2021

Reduced Brain Activation in Response to Social Cognition Tasks in Autism Spectrum Disorder with and without Depression

Ohtani T, Matsuo K, Sutoh C, Oshima F, Hirano Y, Wakabayashi A, Shimizu E

Neuropsychiatric Disease and Treatment 2021, 17:3015-3024

Published Date: 28 September 2021

Impact of the COVID-19 Pandemic on Family Wellbeing in the Context of Neurodevelopmental Disorders

Rizzo R, Karlov L, Maugeri N, di silvestre S, Eapen V

Neuropsychiatric Disease and Treatment 2021, 17:3007-3014

Published Date: 24 September 2021

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study

Baune BT, Florea I, Ebert B, Touya M, Ettrup A, Hadi M, Ren H

Neuropsychiatric Disease and Treatment 2021, 17:2995-3006

Published Date: 23 September 2021

The Association Between Hypoxia Improvement and Electroconvulsive Therapy for Major Depressive Disorder

Bian Z, Li H, Liu Y, Cao Y, Kang Y, Yu Y, Zhang F, Li C, Kang Y, Wang F

Neuropsychiatric Disease and Treatment 2021, 17:2987-2994

Published Date: 22 September 2021

Current Perspectives on the Assessment and Management of Gait Disorders in Parkinson’s Disease

Smith MD, Brazier DE, Henderson EJ

Neuropsychiatric Disease and Treatment 2021, 17:2965-2985

Published Date: 21 September 2021

Severity of Depressive Symptoms is Associated with Venous Thromboembolism in Hospitalized Patients with a Major Depressive Episode

Yoshizawa K, Takeshima M, Ishino S, Ogasawara M, Fujiwara D, Itoh Y, Imanishi A, Ohta H, Mishima K

Neuropsychiatric Disease and Treatment 2021, 17:2955-2963

Published Date: 21 September 2021

Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey

Ishigooka J, Hoshino T, Imai T, Yoshida H, Ono M, Ota M, Moriguchi Y, Fujikawa K, Shintani A, Fernandez JL

Neuropsychiatric Disease and Treatment 2021, 17:2915-2924

Published Date: 10 September 2021

Risk Factors and Neurologic Outcomes in Patients with Traumatic Brain Injury and Coagulopathy Within 72 h After Surgery

Chang T, Yan X, Zhao C, Zhang Y, Wang B, Gao L

Neuropsychiatric Disease and Treatment 2021, 17:2905-2913

Published Date: 10 September 2021

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder

Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D

Neuropsychiatric Disease and Treatment 2021, 17:2885-2904

Published Date: 9 September 2021

Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project

Konno Y, Fujino Y, Ikenouchi A, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R

Neuropsychiatric Disease and Treatment 2021, 17:2867-2876

Published Date: 7 September 2021

Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder

Pan C, Zhao Y, Xie H, Zhou Y, Duan R, Li Y, Jia Y, Peng T

Neuropsychiatric Disease and Treatment 2021, 17:2859-2866

Published Date: 7 September 2021

Prevalence of Symptoms of Anxiety Among Residents of Kabul During Pandemic of COVID-19: A Report from Capital of Afghanistan

Rasib AR, Nemat A, Azimi M, Zaki N, Sediqi MF, Raufi N, Asady A

Neuropsychiatric Disease and Treatment 2021, 17:2841-2846

Published Date: 29 August 2021

Mental Health Outcomes among Frontline Health-Care Workers at Eka Kotebe National COVID-19 Treatment Center, Addis Ababa, Ethiopia, 2020: A Cross-Sectional Study

Habtamu Y, Admasu K, Tullu M, Damene W, Birhanu A, Beyero T, Birhanu Tereda A

Neuropsychiatric Disease and Treatment 2021, 17:2831-2840

Published Date: 28 August 2021

High Uric Acid Level Predicts Early Neurological Deterioration in Intracerebral Hemorrhage

Gong X, Lu Z, Feng X, Yuan K, Zhang M, Cheng X, Xue M, Yu L, Lu J, Yu C

Neuropsychiatric Disease and Treatment 2021, 17:2803-2809

Published Date: 24 August 2021

Clinical Characteristics and Risk Factors of Cerebral Hemorrhage in Patients with Occult Malignant Tumors

Zhao Y, Xie H, Pan C, Yao Y, Gong Z, Li Y, Jia Y

Neuropsychiatric Disease and Treatment 2021, 17:2729-2738

Published Date: 19 August 2021

Myxedema Psychosis: Systematic Review and Pooled Analysis

Mohamed MFH, Danjuma M, Mohammed M, Mohamed S, Siepmann M, Barlinn K, Suwileh S, Abdalla L, Al-Mohanadi D, Silva Godínez JC, Elzouki AN, Siepmann T

Neuropsychiatric Disease and Treatment 2021, 17:2713-2728

Published Date: 18 August 2021

Regional Neural Activity Changes in Parkinson’s Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients

Xing Y, Fu S, Li M, Ma X, Liu M, Liu X, Huang Y, Xu G, Jiao Y, Wu H, Jiang G, Tian J

Neuropsychiatric Disease and Treatment 2021, 17:2697-2706

Published Date: 17 August 2021

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

Iyo M, Ishigooka J, Nakamura M, Sakaguchi R, Okamoto K, Mao Y, Tsai J, Fitzgerald A, Takai K, Higuchi T

Neuropsychiatric Disease and Treatment 2021, 17:2683-2695

Published Date: 16 August 2021

Correlations Between Working Memory Impairment and Neurometabolites of the Prefrontal Cortex in Drug-Naive Obsessive-Compulsive Disorder

Yue J, Zhong S, Luo A, Lai S, He T, Luo Y, Wang Y, Zhang Y, Shen S, Huang H, Wen S, Jia Y

Neuropsychiatric Disease and Treatment 2021, 17:2647-2657

Published Date: 14 August 2021

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study

Wilkowska A, Włodarczyk A, Gałuszko-Węgielnik M, Wiglusz MS, Cubała WJ

Neuropsychiatric Disease and Treatment 2021, 17:2637-2646

Published Date: 14 August 2021

Association of Childbirth Pain with Postnatal Depressive and Anxiety Disorders in Nulliparous Parturients: A Prospective Study

Tan CW, Tan HS, Sultana R, Chui A, Chua TE, Chen H, Sng BL

Neuropsychiatric Disease and Treatment 2021, 17:2625-2636

Published Date: 13 August 2021

Association Between NR4A2 Gene Polymorphism and Depressive Symptoms and Antidepressant Effect

Song X, Sun N, Zhang A, Lei L, Li X, Liu Z, Wang Y, Yang C, Zhang K

Neuropsychiatric Disease and Treatment 2021, 17:2613-2623

Published Date: 10 August 2021

Methylation of the RIN3 Promoter is Associated with Transient Ischemic Stroke/Mild Ischemic Stroke with Early Cognitive Impairment

Miao M, Yuan F, Ma X, Yang H, Gao X, Zhu Z, Bi J

Neuropsychiatric Disease and Treatment 2021, 17:2587-2598

Published Date: 10 August 2021

Disability Status and Its Influencing Factors Among Stroke Patients in Northeast China: A 3-Year Follow-Up Study

Lv Y, Sun Q, Li J, Zhang W, He Y, Zhou Y

Neuropsychiatric Disease and Treatment 2021, 17:2567-2573

Published Date: 7 August 2021

Interaction of Insomnia and Somatization with Post-Traumatic Stress Disorder in Pregnant Women During the COVID-19 Pandemic

Zhang S, Zhou Y, Ge LK, Zeng L, Liu Z, Qian W, Yang J, Zhou X, Wei GX, Zhang X

Neuropsychiatric Disease and Treatment 2021, 17:2539-2547

Published Date: 6 August 2021

Maternal and Paternal Depression During Pregnancy in China: Prevalence, Correlates, and Network Analysis [Corrigendum]

Zhang Y, Sun H, Li W, Luo X, Liu T, Fang F, Xiao J, Garg S, Yang Y, Chen Y

Neuropsychiatric Disease and Treatment 2021, 17:2527-2528

Published Date: 3 August 2021

Electroacupuncture Improves Cerebral Ischemic Injury by Enhancing the EPO-JAK2-STAT5 Pathway in Rats

Liu F, Lu Z, Li Z, Wang S, Zhuang L, Hong M, Huang K

Neuropsychiatric Disease and Treatment 2021, 17:2489-2498

Published Date: 30 July 2021

High Serum Levels of iNOS and MIP-1α are Associated with Post-Stroke Depression

Wang X, Fang C, Liu X, Wei W, Zhang M, Chen S, Shi F

Neuropsychiatric Disease and Treatment 2021, 17:2481-2487

Published Date: 28 July 2021

Predictive Values of the SeLECT Score and IL-1β for Post-Stroke Epilepsy

Shen L, Yang J, Tang Y

Neuropsychiatric Disease and Treatment 2021, 17:2465-2472

Published Date: 27 July 2021

Social-Emotional Development and Associated Risk Factors in Chinese Toddlers with Cerebral Palsy

Wu Y, Tang J, Chen Y, Huang Y

Neuropsychiatric Disease and Treatment 2021, 17:2451-2463

Published Date: 24 July 2021

A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression

Wang Y, Liu X, Peng D, Wu Y, Su Y, Xu J, Ma X, Li Y, Shi J, Cheng X, Rong H, Fang Y

Neuropsychiatric Disease and Treatment 2021, 17:2441-2449

Published Date: 23 July 2021

Role of MT1A Polymorphism and Environmental Mercury Exposure on the Montreal Cognitive Assessment (MoCA)

Sirivarasai J, Chaisungnern K, Panpunuan P, Chanprasertyothin S, Chansirikanjana S, Sritara P

Neuropsychiatric Disease and Treatment 2021, 17:2429-2439

Published Date: 22 July 2021

Psychometric Properties of the Chinese Version of the Clinically Useful Depression Outcome Scale for Patients with Major Depressive Disorder

Ma HY, Wang XM, Huang XJ, Yang CJ, Sheng DF, Yang JJ, Xu MZ

Neuropsychiatric Disease and Treatment 2021, 17:2387-2395

Published Date: 21 July 2021

A Case–Control Study on Behavioral Addictions and Neurocognition: Description of the BANCO and BANCO2 Protocols

Hurel E, Grall-Bronnec M, Thiabaud E, Saillard A, Hardouin JB, Challet-Bouju G

Neuropsychiatric Disease and Treatment 2021, 17:2369-2386

Published Date: 20 July 2021

Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K/Akt Signaling Pathway in Vascular Dementia Mice

Wu X, Liu Y, Zhu L, Wang Y, Ren Y, Cheng B, Ren L, Ge K, Li H

Neuropsychiatric Disease and Treatment 2021, 17:2359-2368

Published Date: 17 July 2021

Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D Report

Rush AJ, South C, Jain S, Agha R, Zhang M, Shrestha S, Khan Z, Hassan M, Trivedi MH

Neuropsychiatric Disease and Treatment 2021, 17:2333-2345

Published Date: 14 July 2021

Acupuncture Treatment Reduced the Risk of Coronary Heart Disease in Patients with Depression: A Propensity-Score Matched Cohort Study

Huang CY, Huang MC, Sun MF, Lin CL, Wu MY, Lin WC, Yen HR

Neuropsychiatric Disease and Treatment 2021, 17:2315-2325

Published Date: 12 July 2021

Epilepsy in Older People in Sub-Saharan Africa: A Systematic Review

Bongomin F, Katabira E, Sajatovic M, Kaddumukasa M

Neuropsychiatric Disease and Treatment 2021, 17:2309-2314

Published Date: 12 July 2021

Aβ Influx into the Blood Evoked by Different Blood Aβ Removal Systems: A Potential Therapy for Alzheimer’s Disease

Kitaguchi N, Kawaguchi K, Sakata M, Aoki H, Yamazaki K, Kaneko M, Kinomura J, Kato M, Hasegawa M, Suzuki N, Mizuno M, Yuzawa Y

Neuropsychiatric Disease and Treatment 2021, 17:2291-2308

Published Date: 13 July 2021

Maternal and Paternal Depression During Pregnancy in China: Prevalence, Correlates, and Network Analysis

Zhang Y, Sun H, Li W, Luo X, Liu T, Fang F, Xiao J, Garg S, Yang Y, Chen Y

Neuropsychiatric Disease and Treatment 2021, 17:2269-2280

Published Date: 12 July 2021

A Nomogram to Predict Symptomatic Intracranial Hemorrhage After Intravenous Thrombolysis in Chinese Patients

Guo H, Xu W, Zhang X, Zhang S, Dai Z, Li S, Xie Y, Li Y, Xue J, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:2183-2190

Published Date: 6 July 2021

One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia

Sisay M, Gashaw T, Degefu N, Hagos B, Alemu A, Teshome Z, Admas M, Kibret H, Dessie Y

Neuropsychiatric Disease and Treatment 2021, 17:2173-2182

Published Date: 6 July 2021

Differential Diagnosis in Children with Autistic Symptoms and Subthreshold ADOS Total Score: An Observational Study

De Giacomo A, Craig F, Palermo G, Coppola A, Margari M, Campanozzi S, Margari L, Turi M

Neuropsychiatric Disease and Treatment 2021, 17:2163-2172

Published Date: 5 July 2021

Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile

de Filippis R, Gaetano R, Schoretsanitis G, Verde G, Oliveti CA, Kane JM, Segura-Garcia C, De Fazio P

Neuropsychiatric Disease and Treatment 2021, 17:2141-2150

Published Date: 1 July 2021

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model

Chen Q, Yin Y, Li L, Zhang Y, He W, Shi Y

Neuropsychiatric Disease and Treatment 2021, 17:2129-2139

Published Date: 30 June 2021

Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats

Wesołowska A, Rychtyk J, Gdula-Argasińska J, Górecka K, Wilczyńska-Zawal N, Jastrzębska-Więsek M, Partyka A

Neuropsychiatric Disease and Treatment 2021, 17:2105-2127

Published Date: 25 June 2021

MicroRNA-126a-5p Exerts Neuroprotective Effects on Ischemic Stroke via Targeting NADPH Oxidase 2

Tan Y, Zhou F, Yang D, Zhang X, Zeng M, Wan L

Neuropsychiatric Disease and Treatment 2021, 17:2089-2103

Published Date: 25 June 2021

Physical and Mental Fatigue in Subjects Recovered from COVID-19 Infection: A Case–Control Study

Elanwar R, Hussein M, Magdy R, Eid RA, Yassien A, Abdelsattar AS, Alsharaway LA, Fathy W, Hassan A, Kamal YS

Neuropsychiatric Disease and Treatment 2021, 17:2063-2071

Published Date: 22 June 2021

Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease

Hu Y, Guo P, Lian TH, Zuo LJ, Yu SY, Liu L, Jin Z, Yu QJ, Wang RD, Li LX, Piao YS, Zhang W

Neuropsychiatric Disease and Treatment 2021, 17:2041-2051

Published Date: 21 June 2021

Algorithms to Predict Anxiety and Depression Among University Students in China After Analyzing Lifestyles and Sport Habits

Zhang L, Zhao S, Lin Q, Song M, Wu S, Zheng H

Neuropsychiatric Disease and Treatment 2021, 17:2011-2025

Published Date: 21 June 2021

Association of Reduced Tract Integrity with Social Communication Deficits in Preschool Autism Children: A Tract-Based Spatial Statistics Study

Yin Y, Xu S, Li C, Li M, Liu M, Yan J, Lan Z, Zhan W, Jiang G, Tian J

Neuropsychiatric Disease and Treatment 2021, 17:2003-2010

Published Date: 18 June 2021

Do Teachers Confirm Parent’s Ratings of ADHD DSM-IV Criteria? A Study of a Mexican Population

Chamorro Y, Bolaños L, Trejo S, Barrios O, Ramírez-Dueñas ML, Alvarez-Tostado P, Cervantes A, Matute E

Neuropsychiatric Disease and Treatment 2021, 17:1965-1975

Published Date: 16 June 2021

Visualizing Patterns of Medication Switching Among Major Depressive Patients with Various Stability and Difficulty to Treatments

Hung YC, Chen HC, Kuo PH, Lu ML, Huang MC, Chen CH, Wang S, Mao WC, Wu CS, Wu TH

Neuropsychiatric Disease and Treatment 2021, 17:1953-1963

Published Date: 16 June 2021

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

Kawamata Y, Sugawara N, Ishioka M, Kubo K, Suzuki K, Fujii A, Furukori H, Nakagami T, Yasui-Furukori N, Shimoda K

Neuropsychiatric Disease and Treatment 2021, 17:1927-1936

Published Date: 15 June 2021

Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile

Zolezzi M, Abouelhassan R, Eltorki Y, Haddad PM, Noorizadeh M

Neuropsychiatric Disease and Treatment 2021, 17:1917-1926

Published Date: 14 June 2021

Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19

Huang Y, Zhou Y, Wei Y, Zeng L, Yang J, Li Y, Song X, Li H, He H, Li T, Wu K, Yang M, Wu F, Ning Y, Zhang X

Neuropsychiatric Disease and Treatment 2021, 17:1907-1915

Published Date: 14 June 2021

Cortical Pathways or Mechanism in the Face Inversion Effect in Patients with First-Episode Schizophrenia

Liu Y, Bi T, Kuang Q, Zhang B, Wu H, Li H, Zhang B, Zhao J, Ning Y, She S, Zheng Y

Neuropsychiatric Disease and Treatment 2021, 17:1893-1906

Published Date: 10 June 2021

Eye Avoidance of Threatening Facial Expressions in Parents of Children with ASD

Yang T, Li D, Zhang Y, Zhang L, Li H, Ji GJ, Yang Z, Zhang L, Zhu C, Wang K

Neuropsychiatric Disease and Treatment 2021, 17:1869-1879

Published Date: 9 June 2021

Met and Unmet Needs in an Inpatient Psychiatry Setting in Spain

Gomez-Sanchez-Lafuente C, Guzman-Parra J, Lopez-Zambrano MA, Moreno-Kustner B, Mayoral-Cleries F

Neuropsychiatric Disease and Treatment 2021, 17:1859-1868

Published Date: 8 June 2021

Periventricular White Matter Hyperintensity in Males is Associated with Post-Stroke Depression Onset at 3 Months

Tu XQ, Lai ZH, Zhang Y, Ding KQ, Ma FY, Yang GY, He JR, Zeng LL

Neuropsychiatric Disease and Treatment 2021, 17:1839-1857

Published Date: 8 June 2021

Updated Review on the Diagnosis and Primary Management of Psychogenic Nonepileptic Seizure Disorders

Lanzillotti AI, Sarudiansky M, Lombardi NR, Korman GP, D´Alessio L

Neuropsychiatric Disease and Treatment 2021, 17:1825-1838

Published Date: 4 June 2021

Neuroprotective Effects and Related Mechanisms of Echinacoside in MPTP-Induced PD Mice

Zhang ZN, Hui Z, Chen C, Liang Y, Tang LL, Wang SL, Xu CC, Yang H, Zhang JS, Zhao Y

Neuropsychiatric Disease and Treatment 2021, 17:1779-1792

Published Date: 3 June 2021

Psychiatric Emergencies During the Covid-19 Pandemic: A 6-Month Observational Study

Di Lorenzo R, Frattini N, Dragone D, Farina R, Luisi F, Ferrari S, Bandiera G, Rovesti S, Ferri P

Neuropsychiatric Disease and Treatment 2021, 17:1763-1778

Published Date: 3 June 2021

Combined Effects of Mother’s, Father’s and Teacher’s Psychological Distress on Schoolchildren’s Mental Health Symptoms

Li S, Na J, Mu H, Li Y, Liu L, Zhang R, Sun J, Li Y, Sun W, Pan G, Yan L

Neuropsychiatric Disease and Treatment 2021, 17:1735-1743

Published Date: 3 June 2021

High Mobility Group Box 1/Toll-like Receptor 4 Signaling Increases GABRB3 Expression in Alcohol Exposure

Sun G, Qi X, Wang W, Li X, Luo C, Bai S, Xu S, Zhong X, Huang C, Zhu X, Huang Z

Neuropsychiatric Disease and Treatment 2021, 17:1725-1732

Published Date: 1 June 2021

Clinical Analysis of Bilateral Thalamic Infarction Caused by Percheron Artery Occlusion

Chen P, Hao MM, Chen Y, Zhang H, Wang Z, Zhao B, Xue Y, Chai Y, Huang YF, Zhu J

Neuropsychiatric Disease and Treatment 2021, 17:1707-1712

Published Date: 28 May 2021

Value of Combining of the NLR and the Fibrinogen Level for Predicting Stroke-Associated Pneumonia

Cheng W, Chen L, Yu H, Lu D, Yu R, Chen J

Neuropsychiatric Disease and Treatment 2021, 17:1697-1705

Published Date: 28 May 2021

Social Inferences as Mediators of Wellbeing in Depression

Giurgi-Oncu C, Bredicean C, Frandeș M, Enătescu V, Papavă I, Riviș I, Ursoniu S

Neuropsychiatric Disease and Treatment 2021, 17:1679-1687

Published Date: 27 May 2021

Eating Disorders and the Use of Cognitive Enhancers and Psychostimulants Among University Students: A Cross-Sectional Study

Damiri B, Safarini OA, Nazzal Z, Abuhassan A, Farhoud A, Ghanim N, Al Ali R, Suhail M, Qino M, Zamareh M, Thabaleh A, Zahran J

Neuropsychiatric Disease and Treatment 2021, 17:1633-1645

Published Date: 25 May 2021

Transient Global Amnesia: Risk Factors, Imaging Features, and Prognosis

He S, Ye Z, Yang Q, Lin J, Chen X, Chen Z, Chen L

Neuropsychiatric Disease and Treatment 2021, 17:1611-1619

Published Date: 25 May 2021

Psychiatric Disorders of Neurocysticercosis: Narrative Review

El-Kady AM, Allemailem KS, Almatroudi A, Abler B, Elsayed M

Neuropsychiatric Disease and Treatment 2021, 17:1599-1610

Published Date: 25 May 2021

Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations

Jackson R, Brams MN, Citrome L, Hoberg AR, Isaacson SH, Kane JM, Kumar R

Neuropsychiatric Disease and Treatment 2021, 17:1589-1597

Published Date: 24 May 2021

Phantom Limb Pain and Sensations in Chinese Malignant Tumor Amputees: A Retrospective Epidemiological Study

Jiang S, Zheng K, Wang W, Pei Y, Qiu E, Zhu G

Neuropsychiatric Disease and Treatment 2021, 17:1579-1587

Published Date: 21 May 2021

Ventilation Adjustment in ECT During COVID-19: Voluntary Hyperventilation is an Effective Strategy

de Arriba-Arnau A, Dalmau Llitjos A, Soria V, Labad J, Menchón JM, Urretavizcaya M

Neuropsychiatric Disease and Treatment 2021, 17:1563-1569

Published Date: 20 May 2021

Temporal Dynamics in Degree Centrality of Brain Functional Connectome in First-Episode Schizophrenia with Different Short-Term Treatment Responses: A Longitudinal Study

Wang Y, Jiang Y, Su W, Xu L, Wei Y, Tang Y, Zhang T, Tang X, Hu Y, Cui H, Wang J, Yao D, Luo C, Wang J

Neuropsychiatric Disease and Treatment 2021, 17:1505-1516

Published Date: 18 May 2021

Cognitive Impairment and Associated Factors Among Chronic Kidney Disease Patients: A Comparative Cross-Sectional Study

Gela YY, Getu AA, Adane A, Ayal BM, Akalu Y, Ambelu A, Diress M, Yeshaw Y

Neuropsychiatric Disease and Treatment 2021, 17:1483-1492

Published Date: 17 May 2021

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]

Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G

Neuropsychiatric Disease and Treatment 2021, 17:1481-1482

Published Date: 17 May 2021

Late-Onset Leukodystrophy Mimicking Hereditary Spastic Paraplegia without Diffuse Leukodystrophy on Neuroimaging

Zhang T, Yan C, Liu Y, Cao L, Ji K, Li D, Chi L, Zhao Y

Neuropsychiatric Disease and Treatment 2021, 17:1451-1458

Published Date: 12 May 2021

Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population

Cui X, Xin WQ, Wang B, Zhao Y, Hou C, Cai S, Peng C, Wang Z, Li J, Huan L, Chen L, Yang X

Neuropsychiatric Disease and Treatment 2021, 17:1443-1449

Published Date: 12 May 2021

Psychological Impact of COVID-19, Isolation, and Quarantine: A Cross-Sectional Study

Jassim G, Jameel M, Brennan E, Yusuf M, Hasan N, Alwatani Y

Neuropsychiatric Disease and Treatment 2021, 17:1413-1421

Published Date: 11 May 2021

Mechanism of Autophagy Regulation in MPTP-Induced PD Mice via the mTOR Signaling Pathway by Echinacoside

Zhang ZN, Hui Z, Chen C, Liang Y, Tang LL, Wang SL, Xu CC, Yang H, Zhao Y, Zhang JS

Neuropsychiatric Disease and Treatment 2021, 17:1397-1411

Published Date: 10 May 2021

Self-Reported Symptoms of Depression, Anxiety, and Stress Among Healthcare Workers in Ethiopia During the COVID-19 Pandemic: A Cross-Sectional Study

Jemal K, Deriba BS, Geleta TA, Tesema M, Awol M, Mengistu E, Annous Y

Neuropsychiatric Disease and Treatment 2021, 17:1363-1373

Published Date: 6 May 2021

Depression and Related Factors in Patients with Parkinson’s Disease at High Altitude

Cao Y, Li G, Xue J, Zhang G, Gao S, Huang Y, Zhu A

Neuropsychiatric Disease and Treatment 2021, 17:1353-1362

Published Date: 6 May 2021

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease

Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM

Neuropsychiatric Disease and Treatment 2021, 17:1311-1339

Published Date: 4 May 2021

The Role of Cognitive Complaints in the Relationship Between Trait Anxiety, Depressive Symptoms, and Subjective Well-Being and Ill-Being in Adult Community Volunteers

Toyoshima K, Ichiki M, Inoue T, Masuya J, Fujimura Y, Higashi S, Kusumi I

Neuropsychiatric Disease and Treatment 2021, 17:1299-1309

Published Date: 30 April 2021

Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia

Fan L, You Y, Fan Y, Shen C, Xue Y

Neuropsychiatric Disease and Treatment 2021, 17:1289-1297

Published Date: 30 April 2021

Comparative Effects of Repetitive Odor Identification and Odor Memory Tasks on Olfactory Engagement in Older Populations – A Pilot fMRI Study

Rai N, Hipolito MM, VanMeter JW, Seth R, Adenuga A, Shelby M, Misiak-Christian M, Nwaokobia C, Manaye KF, Obisesan TO, Nwulia E

Neuropsychiatric Disease and Treatment 2021, 17:1279-1288

Published Date: 30 April 2021

Handgrip Strength and Depression Among Older Chinese Inpatients: A Cross-Sectional Study

Zhang XM, Jiao J, Cao J, Guo N, Zhu C, Li Z, Wu X, Xu T

Neuropsychiatric Disease and Treatment 2021, 17:1267-1277

Published Date: 30 April 2021

Depressive-, Cognitive- or Stroke-Related Risk Factors of Post-Stroke Depression: Which One Could Better Help Clinicians and Patients?

Perrain R, Calvet D, Guiraud V, Mekaoui L, Mas JL, Gorwood P

Neuropsychiatric Disease and Treatment 2021, 17:1243-1251

Published Date: 29 April 2021

Clinical Characteristics and Management of Cerebral Venous Sinus Thrombosis in Patients with Essential Thrombocythemia

Jiao L, Huang X, Fan C, Zhao H, Li Z, Shen H, Chen J, Duan J

Neuropsychiatric Disease and Treatment 2021, 17:1195-1206

Published Date: 22 April 2021

Exploring the Hereditary Nature of Migraine

Bron C, Sutherland HG, Griffiths LR

Neuropsychiatric Disease and Treatment 2021, 17:1183-1194

Published Date: 22 April 2021

Biliverdin Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating the miR-27a-3p/Rgs1 Axis

Li J, Peng L, Bai W, Peng P, Chen W, Yang W, Shao J

Neuropsychiatric Disease and Treatment 2021, 17:1165-1181

Published Date: 22 April 2021

Venlafaxine Inhibits the Apoptosis of SHSY-5Y Cells Through Active Wnt/β-Catenin Signaling Pathway

Geng R, Li H, Wang H, Ye C, Mao Y, Huang X

Neuropsychiatric Disease and Treatment 2021, 17:1145-1151

Published Date: 21 April 2021

Association Analysis of Polymorphisms in BIN1, MC1R, STARD6 and PVRL2 with Mild Cognitive Impairment in Elderly Carrying APOE ϵ4 Allele

Wu Y, Yin J, Yang B, Tang L, Feng W, Liu X, Zhao X, Cheng Z

Neuropsychiatric Disease and Treatment 2021, 17:1125-1133

Published Date: 21 April 2021

Characteristics of TCM Constitution and Related Biomarkers for Mild Cognitive Impairment

Deng X, Teng J, Nong X, Yu B, Tang L, Liang J, Zou Z, Liu Q, Zhou L, Li Q, Zhao L

Neuropsychiatric Disease and Treatment 2021, 17:1115-1124

Published Date: 20 April 2021

Identifying Subjective Symptoms Associated with Psychomotor Disturbance in Melancholia: A Multiple Regression Analysis Study

Tamada Y, Inoue T, Sekine A, Toda H, Takeshima M, Sasaki M, Shindome K, Morita W, Kuyama N, Ohmae S

Neuropsychiatric Disease and Treatment 2021, 17:1105-1114

Published Date: 19 April 2021

Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis

Hýža M, Šilhán P, Češková E, Skřont T, Kacířová I, Uřinovská R, Grundmann M

Neuropsychiatric Disease and Treatment 2021, 17:1069-1075

Published Date: 14 April 2021

Electroacupuncture Ameliorates Depressive-Like Behaviors in Poststroke Rats via Activating the tPA/BDNF/TrkB Pathway

Dong H, Qin YQ, Sun YC, Yao HJ, Cheng XK, Yu Y, Lu SS

Neuropsychiatric Disease and Treatment 2021, 17:1057-1067

Published Date: 13 April 2021

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder

Ichinose M, Miura I, Horikoshi S, Yamamoto S, Kanno-Nozaki K, Watanabe K, Yabe H

Neuropsychiatric Disease and Treatment 2021, 17:1047-1053

Published Date: 13 April 2021

Construct Validity and Differential Item Functioning of the PHQ-9 Among Health Care Workers: Rasch Analysis Approach

Jiraniramai S, Wongpakaran T, Angkurawaranon C, Jiraporncharoen W, Wongpakaran N

Neuropsychiatric Disease and Treatment 2021, 17:1035-1045

Published Date: 8 April 2021

Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes

Landolt S, Rosemann T, Blozik E, Brüngger B, Huber CA

Neuropsychiatric Disease and Treatment 2021, 17:1021-1034

Published Date: 12 April 2021

Traditional Chinese Formula Xiaoyaosan Alleviates Depressive-Like Behavior in CUMS Mice by Regulating PEBP1-GPX4-Mediated Ferroptosis in the Hippocampus

Jiao H, Yang H, Yan Z, Chen J, Xu M, Jiang Y, Liu Y, Xue Z, Ma Q, Li X, Chen J

Neuropsychiatric Disease and Treatment 2021, 17:1001-1019

Published Date: 6 April 2021

A Systematic Review and Meta-Analysis of Transcranial Direct Current Stimulation to Remediate Age-Related Cognitive Decline in Healthy Older Adults

Indahlastari A, Hardcastle C, Albizu A, Alvarez-Alvarado S, Boutzoukas EM, Evangelista ND, Hausman HK, Kraft J, Langer K, Woods AJ

Neuropsychiatric Disease and Treatment 2021, 17:971-990

Published Date: 29 March 2021

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G

Neuropsychiatric Disease and Treatment 2021, 17:957-970

Published Date: 7 April 2021

Urinary Metabolite Signatures for Predicting Elderly Stroke Survivors with Depression

Chen J, Lv Y, Li X, Xiong J, Liang H, Xie L, Wan C, Chen Y, Wang H, Liu P, Zheng H

Neuropsychiatric Disease and Treatment 2021, 17:925-933

Published Date: 25 March 2021

The Association of Insomnia with Depression and Anxiety Symptoms in Patients Undergoing Noncardiac Surgery

Huang X, Wu D, Wu AS, Wei CW, Gao JD

Neuropsychiatric Disease and Treatment 2021, 17:915-924

Published Date: 25 March 2021

Vagal Nerve Stimulation Protects Against Cerebral Ischemia–Reperfusion Injury in Rats by Inhibiting Autophagy and Apoptosis

Zhang LN, Zhang XW, Li CQ, Guo J, Chen YP, Chen SL

Neuropsychiatric Disease and Treatment 2021, 17:905-913

Published Date: 25 March 2021

Psychometric Properties of the General Anxiety Disorders-7 Scale Using Categorical Data Methods: A Study in a Sample of University Attending Ethiopian Young Adults

Manzar MD, Alghadir AH, Anwer S, Alqahtani M, Salahuddin M, Addo HA, Jifar WW, Alasmee NA

Neuropsychiatric Disease and Treatment 2021, 17:893-903

Published Date: 22 March 2021

Patterns of Migraine in Postmenopausal Women: A Systematic Review

Ornello R, Caponnetto V, Frattale I, Sacco S

Neuropsychiatric Disease and Treatment 2021, 17:859-871

Published Date: 19 March 2021

Monocyte-to-Lymphocyte Ratio is Associated with Depression 3 Months After Stroke

Ding K, Lai Z, Zhang Y, Yang G, He J, Zeng L

Neuropsychiatric Disease and Treatment 2021, 17:835-845

Published Date: 19 March 2021

The Relationship Between Type D Personality and the Complexity of Coronary Artery Disease

Enatescu VR, Cozma D, Tint D, Enatescu I, Simu M, Giurgi-Oncu C, Lazar MA, Mornos C

Neuropsychiatric Disease and Treatment 2021, 17:809-820

Published Date: 18 March 2021

A National Survey of Self-Prescription of Beta-Blockers and Their Relation to Undiscovered Anxiety Among Medical and Pharmacological Students in Saudi Arabia

Alsini A, Alkhodaidi I, Alsini Y, Alsseeni S, Alkhodaidi S, Alsini E, Alsini A, Sindi H, Alswat K

Neuropsychiatric Disease and Treatment 2021, 17:797-807

Published Date: 17 March 2021

Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder

Chen JX, Yin L, Xu HT, Zhang SY, Huang WQ, Li HJ, Li BB, Yang KB, Li Q, Berk M, Su YA

Neuropsychiatric Disease and Treatment 2021, 17:787-795

Published Date: 12 March 2021

Recruitment Challenges for Studies of Deep Brain Stimulation for Treatment-Resistant Depression

Ramasubbu R, Golding S, Williams K, Mackie A, MacQueen G, Kiss ZHT

Neuropsychiatric Disease and Treatment 2021, 17:765-775

Published Date: 10 March 2021

Taiwanese Depression Questionnaire and AD8 Questionnaire for Screening Late-Life Depression in Communities

Wei YC, Huang LY, Lin C, Shyu YC, Chen CK

Neuropsychiatric Disease and Treatment 2021, 17:747-755

Published Date: 9 March 2021

Parkinson’s Disease-Associated Melanin Steal [Retraction]

Hinz M, Stein A, Cole T

Neuropsychiatric Disease and Treatment 2021, 17:733-734

Published Date: 3 March 2021

5-HTP Efficacy and Contraindications [Retraction]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2021, 17:731-732

Published Date: 3 March 2021

Construction and Standardization of Dementia Arabic Scale

Farghaly WM, El Tallawy HN, Mohamed H, El Tallawy SH, Abdelhamed MA

Neuropsychiatric Disease and Treatment 2021, 17:721-729

Published Date: 3 March 2021

Short- and Long-Term Effects of Vitamin D Treatment on Bacillus Calmette-Guerin-Induced Depressive-Like Behavior in Mice

Saleh LA, Almutairi FM, Alorabi WK, Alkuhayli BA, Alzaidi SS, Alzahrani SB, Aljumayi FA, Abduljabbar MH, Alharthi AS, Alsufyani MA, Alhazmi MH, Althobaiti AA, Almutairi FN, Alshehri FS, Altowairqi E, Althobaiti YS

Neuropsychiatric Disease and Treatment 2021, 17:711-720

Published Date: 2 March 2021

Early Post-Stroke Electroacupuncture Promotes Motor Function Recovery in Post-Ischemic Rats by Increasing the Blood and Brain Irisin

Liu L, Zhang Q, Li M, Wang N, Li C, Song D, Shen X, Luo L, Fan Y, Xie H, Wu Y

Neuropsychiatric Disease and Treatment 2021, 17:695-702

Published Date: 1 March 2021

P53/miR-154 Pathway Regulates the Epithelial-Mesenchymal Transition in Glioblastoma Multiforme Cells by Targeting TCF12

Zhu G, Yang S, Wang R, Lei J, Ji P, Wang J, Tao K, Yang C, Ge S, Wang L

Neuropsychiatric Disease and Treatment 2021, 17:681-693

Published Date: 26 February 2021

Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users

Yuferov V, Butelman ER, Randesi M, van den Brink W, Blanken P, van Ree JM, Kreek MJ

Neuropsychiatric Disease and Treatment 2021, 17:659-670

Published Date: 25 February 2021

Peripheral Polyneuropathy and Cognitive Impairment in Type II Diabetes Mellitus

Elsharkawy RE, Abdel Azim GS, Osman MA, Maghraby HM, Mohamed RA, Abdelsalam EM, Ebrahem EE, Seliem NMA

Neuropsychiatric Disease and Treatment 2021, 17:627-635

Published Date: 24 February 2021

Changes in the Practice of Electroconvulsive Therapy in Poland: A Nationwide Survey Comparing Data Between 2005 and 2020

Antosik-Wójcińska AZ, Dominiak M, Mierzejewski P, Jażdżyk P, Gazdag G, Takacs R, Wichniak A

Neuropsychiatric Disease and Treatment 2021, 17:605-612

Published Date: 22 February 2021

Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population

Huang YC, Chien WC, Chung CH, Chang HA, Kao YC, Wan FJ, Huang SH, Chung RJ, Wang RS, Wang BL, Tzeng NS, Sun CA

Neuropsychiatric Disease and Treatment 2021, 17:587-604

Published Date: 22 February 2021

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression

Ni P, Liu M, Wang D, Tian Y, Zhao L, Wei J, Yu X, Qi X, Li X, Yu H, Ni R, Ma X, Deng W, Guo W, Wang Q, Li T

Neuropsychiatric Disease and Treatment 2021, 17:567-574

Published Date: 22 February 2021

Exploring the Impact of Modifiable Factors on Serum BDNF in Psychiatric Patients and Community Controls

Chan G, Rosic T, Pasyk S, Dehghan M, Samaan Z

Neuropsychiatric Disease and Treatment 2021, 17:545-554

Published Date: 17 February 2021

Therapeutic Effect of Idebenone on Rats with Vascular Dementia via the MicroRNA-216a/RSK2/NF-κB Axis

Qian X, Xu Q, Li G, Bu Y, Sun F, Zhang J

Neuropsychiatric Disease and Treatment 2021, 17:533-543

Published Date: 17 February 2021

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]

Zhang M, Han W, Xu Y, Li D, Xue Q

Neuropsychiatric Disease and Treatment 2021, 17:513-514

Published Date: 16 February 2021

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia

Urban-Kowalczyk M, Kotlicka-Antczak M, Strzelecki D, Rudecka E, Śmigielski J

Neuropsychiatric Disease and Treatment 2021, 17:503-512

Published Date: 16 February 2021

Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis

Fowler JC, Cope N, Knights J, Fang H, Skubiak T, Shergill SS, Phiri P, Rathod S, Peters-Strickland T

Neuropsychiatric Disease and Treatment 2021, 17:483-492

Published Date: 12 February 2021

Valproate Reverses Mania-Like Behavior of Clockdelta19 Mouse and Alters Monoamine Neurotransmitters Metabolism in the Hippocampus

Liu S, Wei J, Ni R, Gao T, Ni P, Zhao L, Duan X, Ma X, Sham PC, Li T

Neuropsychiatric Disease and Treatment 2021, 17:471-480

Published Date: 11 February 2021

A Bidirectional View of Migraine and Diet Relationship

Gazerani P

Neuropsychiatric Disease and Treatment 2021, 17:435-451

Published Date: 11 February 2021

The Psychological Experience and Intervention in Post-Acute COVID-19 Inpatients

Rossi Ferrario S, Panzeri A, Cerutti P, Sacco D

Neuropsychiatric Disease and Treatment 2021, 17:413-422

Published Date: 11 February 2021

Serum Albumin Levels and Clinical Outcomes Among Ischemic Stroke Patients Treated with Endovascular Thrombectomy

Gao J, Zhao Y, Du M, Guo H, Wan T, Wu M, Liu L, Wang H, Yin Q, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:401-411

Published Date: 10 February 2021

Hippocampal miRNA-144 Modulates Depressive-Like Behaviors in Rats by Targeting PTP1B

Li Y, Wang N, Pan J, Wang X, Zhao Y, Guo Z

Neuropsychiatric Disease and Treatment 2021, 17:389-399

Published Date: 10 February 2021

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage

Zhang C, Zhong J, Chen WX, Zhang XY, Li YH, Zhou TY, Zou YJ, Lan C, Li L, Lai ZP, Feng H, Hu R

Neuropsychiatric Disease and Treatment 2021, 17:355-363

Published Date: 9 February 2021

Bushen Huoxue Acupuncture Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in SAMP8 Mouse Model of Alzheimer’s Disease

Zhang T, Guan B, Tan S, Zhu H, Ren D, Li R, Xiao L

Neuropsychiatric Disease and Treatment 2021, 17:339-346

Published Date: 5 February 2021

Psychosomatic Stress Responses and Sleep Disturbance Mediate the Effects of Irregular Mealtimes on Presenteeism

Hayashida T, Shimura A, Higashiyama M, Fujimura Y, Ono K, Inoue T

Neuropsychiatric Disease and Treatment 2021, 17:315-321

Published Date: 4 February 2021

Gait and Balance Disorder in Patients with Transient Ischemic Attack or Minor Stroke

Li N, Li J, Gao T, Wang D, Du Y, Zhao X

Neuropsychiatric Disease and Treatment 2021, 17:305-314

Published Date: 3 February 2021

(2R,6R)-Hydroxynorketamine Alleviates Electroconvulsive Shock-Induced Learning Impairment by Inhibiting Autophagy

Zhong X, Ouyang C, Liang W, Dai C, Zhang W

Neuropsychiatric Disease and Treatment 2021, 17:297-304

Published Date: 3 February 2021

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience

Montes JM, Montes P, Hernández-Huerta D

Neuropsychiatric Disease and Treatment 2021, 17:291-296

Published Date: 3 February 2021

Prevalence and Predictors of Postictal Confusion After Electroconvulsive Therapy

Ittasakul P, Jarernrat P, Tor PC

Neuropsychiatric Disease and Treatment 2021, 17:283-289

Published Date: 2 February 2021

Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia

Chen X, Chen C, Ji F, Xu Y, Wang W, Lin X, Jiang D, Song X, Gao X, Tian H, Zhuo C, Zhang J

Neuropsychiatric Disease and Treatment 2021, 17:277-282

Published Date: 29 January 2021

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease

Zhang M, Han W, Xu Y, Li D, Xue Q

Neuropsychiatric Disease and Treatment 2021, 17:269-275

Published Date: 29 January 2021

Schisandrin Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in Mouse Models of Alzheimer’s Disease

Li Q, Wang Q, Guan H, Zhou Y, Liu L

Neuropsychiatric Disease and Treatment 2021, 17:261-268

Published Date: 29 January 2021

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval

Okayasu H, Shinozaki T, Takano Y, Sugawara N, Fujii K, Yasui-Furukori N, Ozeki Y, Shimoda K

Neuropsychiatric Disease and Treatment 2021, 17:239-249

Published Date: 27 January 2021

Reliability and Validity of the Chen ADHD Scale (C-ADHDS)

Chen YL, Chen VCH, Gossop M

Neuropsychiatric Disease and Treatment 2021, 17:229-237

Published Date: 27 January 2021

Factor Structure and Measurement Invariance of the Hospital Anxiety and Depression Scale Across the Peripartum Period Among Pregnant Japanese Women

Ogawa M, Watanabe Y, Motegi T, Fukui N, Hashijiri K, Tsuboya R, Sugai T, Egawa J, Araki R, Haino K, Yamaguchi M, Nishijima K, Enomoto T, Someya T

Neuropsychiatric Disease and Treatment 2021, 17:221-227

Published Date: 26 January 2021

Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study

Qiao S, Wu H, Liu L, Wang M, Zhang R, Han T, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:203-212

Published Date: 25 January 2021

Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders

Yang T, Lam RW, Huang J, Su Y, Liu J, Yang X, Yang L, Zhu N, Zhao G, Mao R, Zhou R, Xia W, Liu H, Wang Z, Chen J, Fang Y

Neuropsychiatric Disease and Treatment 2021, 17:183-193

Published Date: 22 January 2021

Anxiety and Stress Among Undergraduate Medical Students of Haramaya University, Eastern Ethiopia

Asfaw H, Fekadu G, Tariku M, Oljira A

Neuropsychiatric Disease and Treatment 2021, 17:139-146

Published Date: 22 January 2021

A Retrospective Study of Patients with GABABR Encephalitis: Therapy, Disease Activity and Prognostic Factors

Wen X, Wang B, Wang C, Han C, Guo S

Neuropsychiatric Disease and Treatment 2021, 17:99-110

Published Date: 18 January 2021

Behavior Disorder and Social Function Impairment in Children with Basal Ganglia Germ Cell Tumors

Lv W, Feng J, Chen L, Liu S, Qiu X

Neuropsychiatric Disease and Treatment 2021, 17:91-98

Published Date: 14 January 2021

Implementing Measurement-Based Care for Depression: Practical Solutions for Psychiatrists and Primary Care Physicians

Hong RH, Murphy JK, Michalak EE, Chakrabarty T, Wang Z, Parikh SV, Culpepper L, Yatham LN, Lam RW, Chen J

Neuropsychiatric Disease and Treatment 2021, 17:79-90

Published Date: 14 January 2021

Clinical Manifestations, Fluid Changes and Neuroimaging Alterations in Patients with General Paresis of the Insane

Gao JH, Li WR, Xu DM, Zheng BW, Huang YM, Wu WQ, Zhang W

Neuropsychiatric Disease and Treatment 2021, 17:69-78

Published Date: 13 January 2021

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden [Corrigendum]

Modugno N, Antonini A, Tessitore A, Marano P, Pontieri FE, Tambasco N, Canesi M, Fabbrini G, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Gualberti G, Lopiano L

Neuropsychiatric Disease and Treatment 2021, 17:67-68

Published Date: 13 January 2021

MicroRNA-488-3p Regulates Neuronal Cell Death in Cerebral Ischemic Stroke Through Vacuolar Protein Sorting 4B (VPS4B)

Zhou L, Yang W, Yao E, Li H, Wang J, Wang K, Zhong X, Peng Z, Huang X

Neuropsychiatric Disease and Treatment 2021, 17:41-55

Published Date: 7 January 2021

Characterizations of Ischemic Stroke Complications in Cardiac Myxoma Patients at a Single Institution in Eastern China

Zhang Y, Ye Z, Fu Y, Zhang Z, Ye Q, Chen F, Cheng J

Neuropsychiatric Disease and Treatment 2021, 17:33-40

Published Date: 7 January 2021

The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study

Knez R, Stevanovic D, Nasic S, Doric A, Wentz E

Neuropsychiatric Disease and Treatment 2021, 17:19-32

Published Date: 6 January 2021